Drivers of variation in postpartum opioid prescribing across hospitals participating in a statewide maternity care quality collaborative
© 2023 The Authors. Birth published by Wiley Periodicals LLC..
BACKGROUND: We describe variation in postpartum opioid prescribing across a statewide quality collaborative and assess the proportion due to practitioner and hospital characteristics.
METHODS: We assessed postpartum prescribing data from nulliparous, term, singleton, vertex births between January 2020 and June 2021 included in the clinical registry of a statewide obstetric quality collaborative funded by Blue Cross Blue Shield of Michigan. Data were summarized using descriptive statistics. Mixed effect logistic regression and linear models adjusted for patient characteristics and assessed practitioner- and hospital-level predictors of receiving a postpartum opioid prescription and prescription size. Relative contributions of practitioner and hospital characteristics were assessed using the intraclass correlation coefficient.
RESULTS: Of 40,589 patients birthing at 68 hospitals, 3.0% (872/29,412) received an opioid prescription after vaginal birth and 87.8% (9812/11,177) received one after cesarean birth, with high variation across hospitals. In adjusted models, the strongest patient-level predictors of receiving a prescription were cesarean birth (aOR 899.1, 95% CI 752.8-1066.7) and third-/fourth-degree perineal laceration (aOR 25.7, 95% CI 17.4-37.9). Receiving care from a certified nurse-midwife (aOR 0.63, 95% CI 0.48-0.82) or family medicine physician (aOR 0.60, 95%CI 0.39-0.91) was associated with lower prescribing rates. Hospital-level predictors included receiving care at hospitals with <500 annual births (aOR 4.07, 95% CI 1.61-15.0). A positive safety culture was associated with lower prescribing rates (aOR 0.37, 95% CI 0.15-0.88). Much of the variation in postpartum prescribing was attributable to practitioners and hospitals (prescription receipt: practitioners 25.1%, hospitals 12.1%; prescription size: practitioners 5.4%, hospitals: 52.2%).
DISCUSSION: Variation in postpartum opioid prescribing after birth is high and driven largely by practitioner- and hospital-level factors. Opioid stewardship efforts targeted at both the practitioner and hospital level may be effective for reducing opioid prescribing harms.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2023 |
|---|---|
| Enthalten in: |
Birth (Berkeley, Calif.) - (2023) vom: 30. Dez. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Peahl, Alex F [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cesarean birth |
|---|
| Anmerkungen: |
Date Revised 30.12.2023 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1111/birt.12809 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM366494244 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM366494244 | ||
| 003 | DE-627 | ||
| 005 | 20240108140949.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240108s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/birt.12809 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1246.xml |
| 035 | |a (DE-627)NLM366494244 | ||
| 035 | |a (NLM)38158784 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Peahl, Alex F |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Drivers of variation in postpartum opioid prescribing across hospitals participating in a statewide maternity care quality collaborative |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 30.12.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a © 2023 The Authors. Birth published by Wiley Periodicals LLC. | ||
| 520 | |a BACKGROUND: We describe variation in postpartum opioid prescribing across a statewide quality collaborative and assess the proportion due to practitioner and hospital characteristics | ||
| 520 | |a METHODS: We assessed postpartum prescribing data from nulliparous, term, singleton, vertex births between January 2020 and June 2021 included in the clinical registry of a statewide obstetric quality collaborative funded by Blue Cross Blue Shield of Michigan. Data were summarized using descriptive statistics. Mixed effect logistic regression and linear models adjusted for patient characteristics and assessed practitioner- and hospital-level predictors of receiving a postpartum opioid prescription and prescription size. Relative contributions of practitioner and hospital characteristics were assessed using the intraclass correlation coefficient | ||
| 520 | |a RESULTS: Of 40,589 patients birthing at 68 hospitals, 3.0% (872/29,412) received an opioid prescription after vaginal birth and 87.8% (9812/11,177) received one after cesarean birth, with high variation across hospitals. In adjusted models, the strongest patient-level predictors of receiving a prescription were cesarean birth (aOR 899.1, 95% CI 752.8-1066.7) and third-/fourth-degree perineal laceration (aOR 25.7, 95% CI 17.4-37.9). Receiving care from a certified nurse-midwife (aOR 0.63, 95% CI 0.48-0.82) or family medicine physician (aOR 0.60, 95%CI 0.39-0.91) was associated with lower prescribing rates. Hospital-level predictors included receiving care at hospitals with <500 annual births (aOR 4.07, 95% CI 1.61-15.0). A positive safety culture was associated with lower prescribing rates (aOR 0.37, 95% CI 0.15-0.88). Much of the variation in postpartum prescribing was attributable to practitioners and hospitals (prescription receipt: practitioners 25.1%, hospitals 12.1%; prescription size: practitioners 5.4%, hospitals: 52.2%) | ||
| 520 | |a DISCUSSION: Variation in postpartum opioid prescribing after birth is high and driven largely by practitioner- and hospital-level factors. Opioid stewardship efforts targeted at both the practitioner and hospital level may be effective for reducing opioid prescribing harms | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a cesarean birth | |
| 650 | 4 | |a dilation and curettage | |
| 650 | 4 | |a pain management | |
| 650 | 4 | |a quality improvement | |
| 650 | 4 | |a vaginal birth | |
| 700 | 1 | |a Low, Lisa Kane |e verfasserin |4 aut | |
| 700 | 1 | |a Langen, Elizabeth S |e verfasserin |4 aut | |
| 700 | 1 | |a Moniz, Michelle H |e verfasserin |4 aut | |
| 700 | 1 | |a Aaron, Bryan |e verfasserin |4 aut | |
| 700 | 1 | |a Hu, Hsou Mei |e verfasserin |4 aut | |
| 700 | 1 | |a Waljee, Jennifer |e verfasserin |4 aut | |
| 700 | 1 | |a Townsel, Courtney |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Birth (Berkeley, Calif.) |d 1992 |g (2023) vom: 30. Dez. |w (DE-627)NLM013544349 |x 1523-536X |7 nnns |
| 773 | 1 | 8 | |g year:2023 |g day:30 |g month:12 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/birt.12809 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 30 |c 12 | ||